US safety data show that elinzanetant caused few adverse events and no new liver-related concerns in women, James Simon, MD, explains.
James Simon, MD
Advertisement
Articles by James Simon, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
3
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5